Search

Navnath Gavande Phones & Addresses

  • Rochester, MI
  • Bellevue, WA
  • Indianapolis, IN
  • West Lafayette, IN
  • Carmel, IN

Work

Company: Purdue university Sep 2011 to Sep 2015 Position: Postdoctoral research fellow

Education

School / High School: Faculty of Pharmacy, The University of Sydney, Australia 2007 Specialities: PhD in Medicinal Chemistry

Skills

Drug Discovery: (9 Years Experien... • SAR development and lead optimization to... • selectivity (to reduce the potential sid... • efficacy/potency and metabolic stability... • computational drug design and biochemist... • method development • asymmetric synthesis and multi-parallel ... • Patch clamp method • Confocal microscopy • Radio-ligand binding assay • RT-PCR and Western blotting • -Secretase and HIV protease in-vitro ass... • and Lead optimization (Molecular docking • Pharmacophore modeling and scaffold hopp... • 3D QSAR • Structure- • ligand- and fragment-based lead optimiza... • Prime • Phase • Maestro • Sybyl • PyMOL • and Accelrys's Discovery Studio. ADME a... • Fluorescence Spectrophotometer • Polarimeter • Microwave and Automated Multiple Organic... • NMR (1H • 13C • 19F and 31P) • 2D NMR (COSY • NOESY • HMBC and HMQC) • and Mass Spectroscopy (LCMS/GCMS/MALDI-T...

Languages

English • Hindi • Marathi

Ranks

Certificate: World Intellectual Property Organization (Wipo), Geneva.

Interests

Social Services • Children • Education • Poverty Alleviation • Science and Technology • Health

Industries

Pharmaceuticals

Resumes

Resumes

Navnath Gavande Photo 1

Assistant Professor

View page
Location:
13900 northeast 12Th St, Bellevue, WA 98005
Industry:
Pharmaceuticals
Work:
Purdue University Sep 2011 - Sep 2015
Postdoctoral Research Fellow

Eli Lilly-Jubilant Drug Discovery Center India Aug 2005 - Feb 2007
Research Associate

Indiana University–Purdue University Indianapolis Aug 2005 - Feb 2007
Assistant Professor
Education:
University of Sydney 2007 - 2013
Doctorates, Doctor of Philosophy, Philosophy, Chemistry, Pharmacy
National Institute of Pharmaceutical Education and Research 2003 - 2005
Master of Science, Masters, Chemistry
Department of Technology, Savitribai Phule Pune University 1999 - 2003
Bachelors, Bachelor of Pharmacy
Skills:
Chromatography
Drug Delivery
Organic Chemistry
Drug Design
Drug Development
Purification
In Vitro
Chemistry
Hplc
Organic Synthesis
Nmr
Pharmacokinetics
Pharmacology
Medicinal Chemistry
Drug Discovery
Interests:
Social Services
Children
Education
Poverty Alleviation
Science and Technology
Health
Languages:
English
Hindi
Marathi
Certifications:
World Intellectual Property Organization (Wipo), Geneva.
General Course on Intellectual Property Rights
Navnath Gavande Photo 2

Navnath Gavande West Lafayette, IN

View page
Education:
Faculty of Pharmacy, The University of Sydney, Australia
2007 to 2011
PhD in Medicinal Chemistry

National Institute of Pharmaceutical Education and Research, Punjab, India
2003 to 2005
Master of Pharmacy in guidance of Prof

University of Pune, India (University Topper)
2003 to 2005
M. Pharm in Pharmaceutical Science

S. G. R. S. College of Pharmacy, University of Pune
Pune, Maharashtra
Jun 1999 to Apr 2003
Bachelor of Pharmacy

Pune University
Pune, Maharashtra
2003
Marketing Management

Skills:
Drug Discovery: (9 Years Experience in Drug Discovery and Development ) Experience in hit to lead identification, SAR development and lead optimization to increase the affinity, selectivity (to reduce the potential side effects), efficacy/potency and metabolic stability. Teaching assistant: Supervised and guided students in organic chemistry, computational drug design and biochemistry laboratory techniques. Emphasized keeping complete and accurate scientific notes. Organic Synthesis Practical experience in carrying out various synthetic organic reactions, method development, asymmetric synthesis and multi-parallel (step) synthesis of small or large molecules in gram and milligram scales. Pharmacology Practical experience in Two-electrode voltage clamp method, Patch clamp method, Confocal microscopy, Radio-ligand binding assay, RT-PCR and Western blotting, -Secretase and HIV protease in-vitro assays. Molecular Modeling Hit to lead discovery (Virtual screening and Molecular docking), and Lead optimization (Molecular docking, Pharmacophore modeling and scaffold hopping, 3D QSAR, Structure-, ligand- and fragment-based lead optimization) using Schrdinger's and Tripos's programs such as Glide, Prime, Phase, Maestro, Sybyl, PyMOL, and Accelrys's Discovery Studio. ADME analysis using QikProp. Analytical Techniques Experience in maintenance and handling of HPLC, Fluorescence Spectrophotometer, Polarimeter, Microwave and Automated Multiple Organic Synthesizer and Flash Chromatography Instruments. Structural Elucidation Well versed with structural elucidation using FT-IR, NMR (1H, 13C, 19F and 31P), 2D NMR (COSY, NOESY, HMBC and HMQC), and Mass Spectroscopy (LCMS/GCMS/MALDI-TOF-TOF).

Publications

Us Patents

Compositions And Methods Relating To Inhibitors Of Pro-Inflammatory Factors For Treatment Of Cancer

View page
US Patent:
20230018174, Jan 19, 2023
Filed:
Jun 23, 2022
Appl. No.:
17/847935
Inventors:
- Detroit MI, US
Navnath S. Gavande - Rochester Hills MI, US
International Classification:
A61K 31/506
C07D 401/14
A61K 45/06
Abstract:
Compositions and methods for treatment of cancer according to aspects of the present disclosure comprise compounds comprising or consisting of: structural formula (I) or (II) disclosed herein, or a salt, isomer, or derivative thereof.

Ku Inhibitors And Their Use

View page
US Patent:
20200308154, Oct 1, 2020
Filed:
May 24, 2017
Appl. No.:
16/303454
Inventors:
- Indianapolis IN, US
Navnath GAVANDE - Indianapolis IN, US
Pamela S. VANDERVERE-CAROZZA - Zionsville IN, US
International Classification:
C07D 405/14
C07D 405/06
C07D 409/06
C12N 15/90
Abstract:
The present disclosure relates to certain compounds having binding affinity for Ku, and uses thereof. Specifically, the present disclosure relates to the use of Ku inhibitors as described herein in site-specific genome engineering technologies, including but not limited to CRISPR/Cas9, Zinc finger nuclease (ZFN), Transcription activator-like effector nuclease (TALEN), and meganuclease.The present disclosure also relates to kits useful for site-specific genome engineering that include at least one compound as described herein.
Navnath S Gavande from Rochester, MI, age ~45 Get Report